<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Alzheimers Disease Progression Prediction Based on Manifold Mapping of Irregularly Sampled Longitudinal Data - Health AI Hub</title>
    <meta name="description" content="This paper introduces R-TNAG, a novel framework designed to predict Alzheimer's disease (AD) progression from irregularly sampled longitudinal structural MRI (s">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Alzheimers Disease Progression Prediction Based on Manifold Mapping of Irregularly Sampled Longitudinal Data</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20154v1" target="_blank">2511.20154v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-25
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Xin Hong, Ying Shi, Yinhao Li, Yen-Wei Chen
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20154v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20154v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces R-TNAG, a novel framework designed to predict Alzheimer's disease (AD) progression from irregularly sampled longitudinal structural MRI (sMRI) data. By projecting sMRI features into a Riemannian manifold and employing a Time-aware Neural ODE alongside an Attention-based Riemannian Gated Recurrent Unit, the model effectively captures the intrinsic geometry and continuous evolution of disease. Experimental results demonstrate that R-TNAG consistently outperforms state-of-the-art methods in both disease status prediction and cognitive score regression, showing robust performance across varying data conditions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research significantly enhances the accuracy and robustness of Alzheimer's disease progression prediction using real-world, often irregular, longitudinal imaging data, which is vital for enabling earlier and more personalized interventions, improving patient stratification for clinical trials, and optimizing long-term care planning.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI model is designed to predict the progression of Alzheimer's Disease (AD) and individual cognitive decline based on longitudinal sMRI data. This application can assist clinicians in: 1) early and more accurate diagnosis or staging of AD, 2) predicting future disease trajectory for better patient management and personalized treatment planning, 3) monitoring treatment efficacy, and 4) facilitating clinical trial design by identifying patients at higher risk of progression.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge of modeling AD progression from irregularly sampled longitudinal sMRI data, a common issue in clinical settings.</li>
                    
                    <li>Proposes the R-TNAG framework, comprising a Riemannian manifold mapping, a Time-aware Neural Ordinary Differential Equation (TNODE), and an Attention-based Riemannian Gated Recurrent Unit (ARGRU).</li>
                    
                    <li>Utilizes Riemannian manifold mapping to project high-dimensional sMRI features into a non-Euclidean space, preserving the intrinsic continuity and nonlinear geometric structure of disease progression.</li>
                    
                    <li>Employs TNODE to model the continuous evolution of latent disease states between discrete, irregularly observed time points, enhancing temporal consistency.</li>
                    
                    <li>Integrates ARGRU to adaptively weigh and integrate historical and current information, specifically designed to manage and leverage data from irregular observation intervals.</li>
                    
                    <li>Achieves superior performance compared to state-of-the-art models in two key predictive tasks: AD disease status classification and cognitive score regression.</li>
                    
                    <li>Demonstrates robust and stable performance across varying sequence lengths and missing data rates, with strong temporal generalizability and confirmed applicability through cross-dataset validation.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The proposed R-TNAG framework first extracts features from high-dimensional sMRI data and maps them into a Riemannian manifold space to capture the intrinsic, non-linear geometric structure of disease progression. On this manifold representation, a Time-aware Neural Ordinary Differential Equation (TNODE) is utilized to model the continuous evolution of latent disease states between irregularly sampled observations. Simultaneously, an Attention-based Riemannian Gated Recurrent Unit (ARGRU) is employed to adaptively integrate historical and current information, specifically designed to handle and leverage data despite irregular observation intervals. This joint design aims to provide robust AD trajectory prediction with improved temporal consistency.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The R-TNAG method consistently outperformed existing state-of-the-art models in both AD disease status prediction (classification) and cognitive score regression. Ablation studies confirmed the individual contributions and complementary roles of each module (Riemannian manifold mapping, TNODE, and ARGRU) in enhancing overall predictive accuracy. Furthermore, the model exhibited strong temporal generalizability, maintaining stable performance across varying sequence lengths and different rates of missing data. Its robustness and applicability in diverse clinical scenarios were further validated through cross-dataset experimentation.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This model offers a significant advancement in AD prognosis by providing more accurate and robust predictions from the often-challenging, irregularly sampled clinical sMRI data. Its ability to handle missing data and irregular intervals makes it highly adaptable for real-world clinical use, potentially enabling earlier and more precise patient stratification, personalized treatment planning, and more effective monitoring of disease progression. This could lead to improved patient outcomes and more efficient allocation of healthcare resources.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the proposed R-TNAG method. Potential implicit limitations common to such models, not mentioned, might include generalizability to diverse populations or specific clinical subtypes, and the interpretability of deep learning models in a clinical context.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions. However, based on the work, potential future directions could involve integrating multi-modal data (e.g., PET, cognitive tests, genetic markers), exploring explainable AI techniques to enhance clinical interpretability, or conducting prospective validation studies in real-world clinical cohorts to further confirm its utility.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Neuroimaging</span>
                    
                    <span class="tag">Predictive Analytics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Alzheimer's Disease</span>
                    
                    <span class="tag tag-keyword">Disease Progression Prediction</span>
                    
                    <span class="tag tag-keyword">Longitudinal Data</span>
                    
                    <span class="tag tag-keyword">Irregular Sampling</span>
                    
                    <span class="tag tag-keyword">Riemannian Manifold</span>
                    
                    <span class="tag tag-keyword">Neural Ordinary Differential Equation</span>
                    
                    <span class="tag tag-keyword">Gated Recurrent Unit</span>
                    
                    <span class="tag tag-keyword">Structural MRI</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Neuroimaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The uncertainty of clinical examinations frequently leads to irregular observation intervals in longitudinal imaging data, posing challenges for modeling disease progression.Most existing imaging-based disease prediction models operate in Euclidean space, which assumes a flat representation of data and fails to fully capture the intrinsic continuity and nonlinear geometric structure of irregularly sampled longitudinal images. To address the challenge of modeling Alzheimers disease (AD) progression from irregularly sampled longitudinal structural Magnetic Resonance Imaging (sMRI) data, we propose a Riemannian manifold mapping, a Time-aware manifold Neural ordinary differential equation, and an Attention-based riemannian Gated recurrent unit (R-TNAG) framework. Our approach first projects features extracted from high-dimensional sMRI into a manifold space to preserve the intrinsic geometry of disease progression. On this representation, a time-aware Neural Ordinary Differential Equation (TNODE) models the continuous evolution of latent states between observations, while an Attention-based Riemannian Gated Recurrent Unit (ARGRU) adaptively integrates historical and current information to handle irregular intervals. This joint design improves temporal consistency and yields robust AD trajectory prediction under irregular sampling.Experimental results demonstrate that the proposed method consistently outperforms state-of-the-art models in both disease status prediction and cognitive score regression. Ablation studies verify the contributions of each module, highlighting their complementary roles in enhancing predictive accuracy. Moreover, the model exhibits stable performance across varying sequence lengths and missing data rates, indicating strong temporal generalizability. Cross-dataset validation further confirms its robustness and applicability in diverse clinical settings.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>10 pages, 3 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>